US4781601046 - Common Stock - After market: 168.1 -0.13 (-0.08%)
Date | Firm | Action | Rating |
---|---|---|---|
2023-01-25 | Atlantic Equities | Maintains | Neutral |
2023-01-25 | Morgan Stanley | Maintains | Equal-Weight |
2023-01-20 | SVB Leerink | Maintains | Outperform |
2022-12-12 | Citigroup | Maintains | Buy |
2022-12-06 | Morgan Stanley | Maintains | Equal-Weight |
2022-12-01 | Morgan Stanley | Maintains | Equal-Weight |
2022-11-18 | Credit Suisse | Initiate | Neutral |
2022-10-19 | Atlantic Equities | Maintains | Neutral |
2022-10-19 | Raymond James | Maintains | Outperform |
2022-10-19 | Morgan Stanley | Maintains | Equal-Weight |
2022-10-18 | Barclays | Initiate | Equal-Weight |
2022-10-12 | Morgan Stanley | Maintains | Equal-Weight |
2022-09-12 | Morgan Stanley | Maintains | Equal-Weight |
2022-07-21 | UBS | Maintains | Neutral |
2022-07-20 | Atlantic Equities | Maintains | Neutral |
2022-07-20 | SVB Leerink | Maintains | Outperform |
2022-07-20 | Raymond James | Maintains | Outperform |
2022-07-20 | Citigroup | Maintains | Buy |
2022-07-13 | Wells Fargo | Maintains | Overweight |
2022-07-08 | Morgan Stanley | Maintains | Equal-Weight |
2022-05-17 | Citigroup | Maintains | Buy |
2022-04-20 | Raymond James | Maintains | Outperform |
2022-04-20 | Credit Suisse | Maintains | Outperform |
2022-04-20 | Citigroup | Maintains | Buy |
2022-04-14 | Raymond James | Maintains | Outperform |
2022-04-12 | Goldman Sachs | Maintains | Neutral |
2022-01-26 | Raymond James | Maintains | Outperform |
2022-01-24 | Morgan Stanley | Maintains | Equal-Weight |
2021-12-17 | Goldman Sachs | Initiate | Neutral |
2021-10-20 | Raymond James | Maintains | Outperform |
Find the competitors with the best analyst ratings on the USA